EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy

Lyuba Y Salih, Nicolas L A Dumaire, Clémence Gieré, Erin Vest, Haya Alkhateeb, Christian P Moritz, Yannick Tholance, Jean-Philippe Camdessanché, Jean-Christophe Antoine, Jérôme Honnorat, Jafar Kafaie, Liberty François-Moutal und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202511413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lyuba Y Salih und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 3, Autoantibodies, Small Fiber Neuropathy, Neuralgia. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale, Agence Nationale de la Recherche, Saint Louis University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sensory neuronopathies (SNN) and small fiber neuropathies (SFN) are debilitating disorders associated with neuropathic pain, yet their underlying mechanisms remain poorly understood. Autoantibodies against fibroblast growth factor receptor 3 define a subset of patients with consistent reports of neuropathic pain harboring a distinct clinical phenotype characterized by small‐fiber and non‐length‐dependent neuropathy, suggesting dorsal root ganglia (DRG) dysfunction. FGFR3‐autoantibody‐positive sera (FGFR3‐AbS) bind to sensory neurons within dorsal root ganglia (DRG). The target of autoantibodies FGFR3 is expressed at the transcript and protein level in human sensory neurons, suggesting that FGFR3‐AbS could find their target in primary afferents. DRG neurons exposed to FGFR3‐AbS rapidly acquired a hyperexcitability phenotype which was linked to mechanical hypersensitivity, mirroring patient‐reported pain symptoms. CRISPR mediated gene editing of FGFR3 in sensory neuron prevented FGFR3‐AbS induced sensitization of sensory neurons and mechanical hypersensitivity. In parallel, epitope mapping reveals extracellular FGFR3 epitopes essential for antibody‐induced sensitization and pain hypersensitivity. Together this work suggests that beyond their role as biomarkers, FGFR3‐AbS are pathogenic in small fiber neuropathy by acting directly on DRG neurons. This positions both FGFR3‐AbS and FGFR3 signaling as actionable therapeutic targets for modulating sensory neuron excitability and treating autoimmune painful neuropathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 3AutoantibodiesSmall Fiber NeuropathyNeuralgiaHumansAnimalsGanglia, SpinalSensory Receptor CellsMice

Stichwörter der Autor:innen

CRISPRFGFR3autoantibodiesdorsal root gangliahyperexcitabilityneuropathic painsensory neuronsmall fiber neuropathy

Substanzen

Receptor, Fibroblast Growth Factor, Type 3AutoantibodiesFGFR3 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
  • Institute For Translational Neuroscience, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
  • MeLiS | CNRS UMR 5284 | INSERM U1314, Synaptopathies and Autoantibodies, Institut National de La Santé et De La Recherche Médicale (INSERM), U1217, Centre National de la Recherche Scientifique (CNRS) UMR5310, Lyon, Fran…
  • Université Claude Bernard Lyon 1, 69000 Lyon, France and University Jean Monnet, Saint-Priest-en-Jarez, France.
  • Department of Neurology, University Hospital of Saint-Etienne, Saint-Etienne, France.
  • Department of Neurology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

ORCID-Profile: Aubin Moutal

Förderung

  • Fondation pour la Recherche Médicale
  • Agence Nationale de la Recherche
  • Saint Louis University
  • CDMRP
  • NINDS NIH HHS
  • Congressionally Directed Medical Research Programs
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Salih, L. Y., Dumaire, N. L. A., Gieré, C., Vest, E., Alkhateeb, H., Moritz, C. P., Tholance, Y., Camdessanché, J. P., Antoine, J. C., Honnorat, J., Kafaie, J., François-Moutal, L., & Moutal, A. (2026). Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy. Advanced Science. https://doi.org/10.1002/advs.202511413

Vancouver

Salih LY, Dumaire NLA, Gieré C, Vest E, Alkhateeb H, Moritz CP, et al. Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy. Advanced Science. 2026. doi:10.1002/advs.202511413

BibTeX
@article{Salih2026,
  author = {Salih, Lyuba Y and Dumaire, Nicolas L A and Gieré, Clémence and Vest, Erin and Alkhateeb, Haya and Moritz, Christian P and Tholance, Yannick and Camdessanché, Jean-Philippe and Antoine, Jean-Christophe and Honnorat, Jérôme and Kafaie, Jafar and François-Moutal, Liberty and Moutal, Aubin},
  title = {Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202511413}
}
Kostenlos starten →